Reducing unnecessary and inappropriate therapy in secondary prevention patients

Similar documents
La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente. Maurizio Gasparini

Εκθορηίζεις απινιδωηή και θνηηόηηηα: μέθοδοι μείωζης ηων θεραπειών απινίδωζης

Tech Corner. ATP in the Fast VT zone

Shock Reduction Strategies Michael Geist E. Wolfson MC

MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI

Programming of Bradycardic Parameters. C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany

Tachyarrhythmia Suspicion and Detection

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

ICD THERAPIES: are they harmful or just high risk markers?

State of the art of ICD programming: Lessons learned and future directions

INNOVATIONS IN DEVICE THERAPY:

Device Update Implantable Cardioverter Defibrillator (ICD) 박상원

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

MADIT-RIT: Simple programming change averts most inappropriate ICD therapy

First question: Does CRT Work in AF?

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

Device detected VT: How much VT is significant and is VT ablation the answer?

Introduction. CLINICAL RESEARCH Clinical Trial Design. Mohammad Saeed 1 *, Mehdi Razavi 1, Curtis G. Neason 2, and Simona Petrutiu 2. Aims.

Novel Approaches to VT Management Glenn M Polin MD

PARAD/PARAD+ : P and R Based Arrhythmia Detection

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

Inappropriate electrical shocks: Tackling the beast

Do All Patients With An ICD Indication Need A BiV Pacing Device?

ICD: Basics, Programming and Trouble-shooting

News der kardialen Device - Therapie! Christian Binggeli! Rhythmologie Klinik St. Anna, Luzern! HerzGefässZentrum Zürich, KlinikImPark, Zürich!

SUBCUTANEOUS ICD ITS JOURNEY FROM PROOF OF CONCEPT TO CURRENT EVOLUTION

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

Dual-Chamber Implantable Cardioverter-Defibrillator

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

Case Description A 25 years old male served in a combat unit for 3 years (GOLANY) Implantation of Dual chamber ICD in 7/2010 due to Severe Non ischemi

Reducing Inappropriate and Appropriate Therapy in Primary Preven7on Pa7ents

SVT Discriminators. Definition of SVT Discrimination. Identify which patient populations might benefit from these features

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

Tachycardia Devices Indications and Basic Trouble Shooting

Journal of Arrhythmia

What You Should Know About Subcutaneous and Transvenous ICD

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Troubleshooting ICD. NASPE Training Lancashire & South Cumbria Cardiac Network

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

HF and CRT: CRT-P versus CRT-D

Declaration of conflict of interest. None

Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

Clinical Results with the Dual-Chamber Cardioverter Defibrillator Phylax AV - Efficacy of the SMART I Discrimination Algorithm

Prophylactic ablation

Is This Thing Working?

CRT response: definition and handling of non-responders

Subcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention

Mitchell Cohen MD FACC FHRS Co-Director of the Heart Center Section Chief, Pediatric Cardiology Phoenix Children s Hospital Professor of Child Health

Cardiac Resynchronization ICD Therapy: What is New?

The implantable cardioverter defibrillator (ICD) reduces

Panagiotis N. Margos MD, Rolf Schomburg MD, Jorg Kynast MD, Ahmed A. Khattab MD, Gert Richardt MD.

HRC Carole Joyce. Bradford Royal Infirmary. Senior Chief Cardiac Physiologist. Pacing & Invasive Services.

Risk Stratification of Sudden Cardiac Death

Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In?

The implantable cardioverter defibrillator (ICD) reduces

Sudden Cardiac Death and Asians Disclosures

State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification

ESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309

THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA

Tailored treatment in Brugada syndrome

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Clinical endpoints for VT/VF suppression in Patients with ICDs: Living longer and feeling better

12 th International Winter Arrhythmia School Collingwood, Ontario February 7, Dr. Derek Yung. MD, FRCPC

Ventricular Arrhythmias

New scientific documents from EHRA Management of patients with defibrillator shocks

The Nuts and Bolts of ICD Therapy

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS

ICD Discrimination Algorithms

ICD Therapy. Disclaimers

ESC Stockholm Arrhythmias & pacing

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

A New Dual Chamber Cardioverter-Defibrillator with Left Atrial Pacing Support

CONTAK RENEWAL 3 AVT CLINICAL SUMMARY

The patient with electric storm

Cardiac Rhythm Device Management. PBL STOP Your acronym for a standardized follow-up

Life-saving shocks are the raisons d être of implantable

Preventing Sudden Death Current & Future Role of ICD Therapy

Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Cardiac Arrhythmias in Acute Coronary Syndrome. Roj Rojjarekampai, MD Thammasart Hospital 26/5/59

The Role of ICD Therapy in Cardiac Resynchronization

Early Experience with the Subcutaneous ICD

Update on Device Innovation (S-ICD, Wearable, Leadless)

Supplementary Online Content

1272 OGINOSAWA Y et al. Circ J 2017; 81: ORIGINAL ARTICLE doi: /circj.CJ

Advanced ICD Concepts

Primary Therapy for High Risk LQT Patients Should Be an ICD

ICD Diagnostics: Making the most of it

LifeVest. Sven Reek, Aarau. Conflict of interest: none

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

HRS Abstract from the ALTITUDE Clinical Science Program as presented at Heart Rhythm Society Conference, May 2011; San Francisco, CA USA

Diagnostic capabilities of the implantable therapeutic systems

A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Transcription:

Reducing unnecessary and inappropriate therapy in secondary prevention patients Maurizio Gasparini, MD Chief of EP and Pacing Unit Humanitas Research Hospital, Rozzano-Milano Italy

Goals of Optimal ICD Programming! Ensure detection and effective therapy for life-threatening VT/VF.! " unnecessary shocks! "" inappropriate Rx for SVT.! "" inappropriate Rx for oversensing. Sorry! "" unecessary Rx for self-terminating VT.! Terminate VT/VF with ATP whenever possible.! Prevent proarrhythmia.

Are there specific features for secondary prevention patients? # SP pts : unique clinical characteristics with more arrhythmic profile # In the recent ICD era, implanted population moved from secondary indication to HF PP indication Very few studies on SP # Which strategies to " unncessary and inappropriate therapies in SP?

Possible strategies to " unnecessary and inappropriate therapies in SP 1. Choice of ICD 2. Choice of device programming

1. ICD : VVI versus DDD

No differences in inappropriate/appropriate shocks in DDD vs VVI ICD in secondary prevention

2. ICD : device programming * Included secondary prevention patients. Clinical Trials of Features to Minimize Shocks Rate Duration SVT vs. VT OS Rejection ATP Sensed Events Shock Faster Rate Longer Duration SVT-VT Discrimination Sensing Confirmation PREPARE (2008) X X (X) X RELEVANT (2009) X x X MADIT-RIT (2012) X X X X ADVANCE III (2013)* ATP X X X PROVIDE (2014) X X X X PAINFREE SST (2015)* X X X X X

(Heart Rhythm 2015;12:926 936)

Extremely low incidence of inappropriate shocks 1.5%/yr 2.5%/yr # Absence of a control group in the general population! # Waiting for results in SP

Faste r Rate Longer Duration SVT-VT Discrimina tion Sensing Confirmat ion PREPARE (2008) X X (X) X RELEVANT (2009) X X X ATP Long detection proven to be effective in PP MADIT-RIT (2012) ADVANCE III (2013)* X X X X X X X PROVIDE (2014) X X X X PAINFREE SST (2015)* X X X X X Is long detection effective in SP too?

SP population is obviously more arrhythmic then HF

Results Time to 1 st therapy

Results Long detection in SP : " 25 % ALL therapy Long detection in SP : " 34 % SHOCKS

36% less shocks!! First time in the Secondary Prevention: # " overall therapies and shocks, # " APPROPRIATE and INAPPROPRIATE shocks

First time in the Secondary Prevention: " APPROPRIATE shocks in long detection In SP too a lot of SELF-TERMINATING TRUE VA!!! " " of APPROPRIATE but UNNECESSARY SHOCKS QOL $$

First time in the Secondary Prevention: " INAPPROPRIATE shocks in long detection In SP too a lot of SELF-TERMINATING SV ARRYTHMIAS!!! " " of INAPPROPRIATE SHOCKS QOL $$

Hypotetical problems long detection-related Sincopal episodes # Syncopal episodes rare, no difference between 2 arms

Definitively According to Programming and Testing Expert Consensus Statement (HRS/EHRA/APHRS/SOLAECE) Heart Rhythm 2015 in press Optimal Rate and Duration Longer Duration Primary Prevention 6-12 s or 30 intervals Class I Secondary Prevention 6-12 s or 30 intervals Class I Detection Rate 185-200 bpm Class I < VT rate - 10 bpm*& < 200 bpm Class IIA *Or detection interval VT CL+ 40 ms For VT window programming: CONSIDER SLOWER CUT OFF RATES if concomitant antiarrhythmic drugs!

Definitively According to Programming and Testing Expert Consensus Statement (HRS/EHRA/APHRS/SOLAECE) Heart Rhythm 2015 in press Optimal Rate and Duration Longer Duration Primary Prevention 6-12 s or 30 intervals Class I Secondary Prevention 6-12 s or 30 intervals Class I Detection Rate 185-200 bpm Class I < VT rate - 10 bpm*& < 200 bpm Class IIA *Or detection interval VT CL+ 40 ms SVT-VT Discrimination Algorithms Class I Program SVT-VT discrimination algorithms ON for rates up to 200 bpm, potentially up to 230 bpm, unless contraindicated.

Conclusions 1. Every effort should be made to unnecessary ICD therapies, especially shocks ( QOL and arrhytmogenic risk) 2. Long detection and high rate cut off are well known to reduce appropriate but UNNECESSARY and INAPPROPRIATE therapy in Primary Prevention (Relevant, MADIT RIT, PROVIDE, ADVANCE III ) 3. According to ADVANCE III results long detection programming allows dramatic UNNECESSARY and INAPPROPRIATE shock reduction in SP too 4. Long detection SHOULD BE FIRST- LINE CHOICE both in Primary and Secondary Prevention